96 related articles for article (PubMed ID: 3028965)
21. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
Altay G; Tulunay C
Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
[TBL] [Abstract][Full Text] [Related]
22. Investigations on ofloxacin: antibacterial activity and influence on the immune system.
Pulverer G; Peters G
Infection; 1986; 14 Suppl 4():S245-7. PubMed ID: 3102386
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal effect of ofloxacin alone and combined with fosfomycin or vancomycin against Staphylococcus aureus in vitro and in sera from volunteers.
Weber P; Boussougant Y; Ichou F; Dutoit C; Carbon C
J Antimicrob Chemother; 1987 Dec; 20(6):839-47. PubMed ID: 3481627
[TBL] [Abstract][Full Text] [Related]
24. The activity of ofloxacin against methicillin-resistant Staphylococcus aureus.
Mraović M; Canić-Radojlović M
Infection; 1986; 14 Suppl 4():S231-2. PubMed ID: 3469151
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa pre-incubated in ofloxacin.
Nielsen B; Nielsen H
Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):227-32. PubMed ID: 3118637
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients.
Naber KG; Adam D; Kees F
Drugs; 1987; 34 Suppl 1():44-50. PubMed ID: 3481328
[TBL] [Abstract][Full Text] [Related]
27. [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
Seibert G; Klesel N; Limbert M; Schrinner E; Winkler I
Arzneimittelforschung; 1984; 34(11):1552-4. PubMed ID: 6596953
[TBL] [Abstract][Full Text] [Related]
28. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
[TBL] [Abstract][Full Text] [Related]
29. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
30. [Susceptibilities of clinical isolates to antibacterial agents. Focusing mainly on ofloxacin (first report). Reported by the Research Group for Testing Ofloxacin Susceptibility of Clinical Isolates].
Kosakai N
Jpn J Antibiot; 1988 Jan; 41(1):71-104. PubMed ID: 3163383
[TBL] [Abstract][Full Text] [Related]
31. Comparative antibacterial activity of new quinolone-carboxylic acid derivatives.
Mitsuhashi S
Rev Infect Dis; 1988; 10 Suppl 1():S27-31. PubMed ID: 3347811
[TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Chau PY; Leung YK; Ng WW
Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
[TBL] [Abstract][Full Text] [Related]
33. Development of resistance to ofloxacin.
Crumplin GC; Odell M
Drugs; 1987; 34 Suppl 1():1-8. PubMed ID: 3325254
[TBL] [Abstract][Full Text] [Related]
34. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the sensitivity of bacteria of various origin to ofloxacin.
Gubina M
Chemioterapia; 1987 Apr; 6(2):79-81. PubMed ID: 3474082
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Cullmann W; Stieglitz M; Baars B; Opferkuch W
Chemotherapy; 1985; 31(1):19-28. PubMed ID: 3156025
[TBL] [Abstract][Full Text] [Related]
37. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
Kumada T; Neu HC
J Antimicrob Chemother; 1985 Nov; 16(5):563-74. PubMed ID: 3865923
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative.
Ikeda S; Yazawa M; Nishimura C
Antiviral Res; 1987 Oct; 8(3):103-13. PubMed ID: 2827566
[TBL] [Abstract][Full Text] [Related]
39. 4-Quinolone interactions with gyrase subunit B inhibitors.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Dec; 35(6):358-62. PubMed ID: 1661337
[TBL] [Abstract][Full Text] [Related]
40. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
